It might be well worth to test the effect of 5,6,7,8-tetrahydrobiopterin supplementation (in an attempt to normalize the function of uncoupled endothelial NO synthase [237,239]) as part of the therapy, e.g. in colon cancer when the tumour cells express NOS-2. This evidence concerns the gene NOS2 and neoplasm.